Rune Boas1,2, Jens Jakob Thune2,3, Steen Pehrson2,4, Lars Køber2,4, Jens C Nielsen5, Lars Videbæk6, Jens Haarbo7, Eva Korup8, Niels Eske Bruun2,9, Axel Brandes6, Hans Eiskjær5, Anna M Thøgersen8, Berit T Philbert4, Jesper Hastrup Svendsen2,4, Ulrik Dixen1,2. 1. Department of Cardiology, Amager Hvidovre University Hospital, University of Copenhagen, Kettegaard Alle 30, 2650 Hvidovre, Denmark. 2. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Department of Cardiology, Bispebjerg Frederiksberg University Hospital, University of Copenhagen, Copenhagen, Denmark. 4. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark. 5. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. 6. Department of Cardiology, Odense University Hospital, Odense, Denmark. 7. Department of Cardiology, Herlev Gentofte University Hospital, Copenhagen, Denmark. 8. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. 9. Department of Cardiology, Zealand University Hospital Roskilde, Roskilde, Denmark.
Abstract
AIMS: Improved risk stratification to identify non-ischaemic heart failure patients who will benefit from primary prophylactic implantable cardioverter-defibrillator (ICD) is needed. We examined the potential of ventricular arrhythmia to identify patients who could benefit from an ICD. METHODS AND RESULTS: A total of 850 non-ischaemic systolic heart failure patients with left ventricle ≤35% and elevated N-terminal pro-brain natriuretic peptides had a 24-h Holter monitor recording performed. We examined present non-sustained ventricular tachycardia (NSVT), defined as ≥3 consecutive premature ventricular contractions (PVCs) with a rate of ≥100/min, and number of PVCs per hour stratified into low (<30) and high burden (≥30) groups. Outcome measures were overall mortality, sudden cardiac death (SCD), and cardiovascular death (CVD). In total, 193 patients died, 49 from SCD and 125 from CVD. Non-sustained ventricular tachycardia (365 patients) was significantly associated with increased all-cause mortality [hazard ratio (HR) 1.47; 95% confidence interval (CI) 1.07-2.03; P = 0.02] and to CVD (HR 1.89; CI 1.25-2.87; P = 0.003). High burden PVC (352 patients) was associated with increased all-cause mortality (HR1.38; CI 1.00-1.90; P = 0.046) and with CVD (HR 1.78; CI 1.19-2.66; P = 0.005). There was no statistically significant association with SCD for neither NSVT nor PVC. In interaction analyses, neither NSVT (P = 0.56) nor high burden of PVC (P = 0.97) was associated with survival benefit from ICD implantation. CONCLUSION: Ventricular arrhythmia in non-ischaemic heart failure patients was associated with a worse prognosis but could not be used to stratify patients to ICD implantation. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Improved risk stratification to identify non-ischaemic heart failure patients who will benefit from primary prophylactic implantable cardioverter-defibrillator (ICD) is needed. We examined the potential of ventricular arrhythmia to identify patients who could benefit from an ICD. METHODS AND RESULTS: A total of 850 non-ischaemic systolic heart failure patients with left ventricle ≤35% and elevated N-terminal pro-brain natriuretic peptides had a 24-h Holter monitor recording performed. We examined present non-sustained ventricular tachycardia (NSVT), defined as ≥3 consecutive premature ventricular contractions (PVCs) with a rate of ≥100/min, and number of PVCs per hour stratified into low (<30) and high burden (≥30) groups. Outcome measures were overall mortality, sudden cardiac death (SCD), and cardiovascular death (CVD). In total, 193 patients died, 49 from SCD and 125 from CVD. Non-sustained ventricular tachycardia (365 patients) was significantly associated with increased all-cause mortality [hazard ratio (HR) 1.47; 95% confidence interval (CI) 1.07-2.03; P = 0.02] and to CVD (HR 1.89; CI 1.25-2.87; P = 0.003). High burden PVC (352 patients) was associated with increased all-cause mortality (HR1.38; CI 1.00-1.90; P = 0.046) and with CVD (HR 1.78; CI 1.19-2.66; P = 0.005). There was no statistically significant association with SCD for neither NSVT nor PVC. In interaction analyses, neither NSVT (P = 0.56) nor high burden of PVC (P = 0.97) was associated with survival benefit from ICD implantation. CONCLUSION: Ventricular arrhythmia in non-ischaemic heart failure patients was associated with a worse prognosis but could not be used to stratify patients to ICD implantation. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Aleksandra Karabinowska-Małocha; Ewa Dziewięcka; Paweł Banyś; Małgorzata Urbańczyk-Zawadzka; Maciej Krupiński; Małgorzata Mielnik; Jacek Łach; Aleksandra Budkiewicz; Piotr Podolec; Łukasz Żydzik; Sylwia Wiśniowska-Śmiałek; Katarzyna Holcman; Magdalena Kostkiewicz; Paweł Rubiś Journal: J Pers Med Date: 2022-02-17
Authors: Pawel P Rubiś; Ewa M Dziewięcka; Paweł Banyś; Małgorzata Urbańczyk-Zawadzka; Maciej Krupiński; Małgorzata Mielnik; Jacek Łach; Andrzej Ząbek; Sylwia Wiśniowska-Śmiałek; Piotr Podolec; Aleksandra Karabinowska; Katarzyna Holcman; Ann C Garlitski Journal: Sci Rep Date: 2021-12-14 Impact factor: 4.379
Authors: James P Curtain; Alice M Jackson; Li Shen; Pardeep S Jhund; Kieran F Docherty; Mark C Petrie; Davide Castagno; Akshay S Desai; Luis E Rohde; Martin P Lefkowitz; Jean-Lucien Rouleau; Michael R Zile; Scott D Solomon; Karl Swedberg; Milton Packer; John J V McMurray Journal: Eur J Heart Fail Date: 2022-01-19 Impact factor: 17.349